We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Probes Promise Exceptional Live Cell Images

By LabMedica International staff writers
Posted on 09 May 2017
Print article
Image: An image generated by cancerous cells labeled with the new chemiluminescent probe (Photo courtesy of Dr. Doron Shabat, Tel Aviv University).
Image: An image generated by cancerous cells labeled with the new chemiluminescent probe (Photo courtesy of Dr. Doron Shabat, Tel Aviv University).
Development of a new generation of chemiluminescent molecules is expected to lead to synthesis of efficient chemiluminescent probes for microscopy that will be suitable for use under physiological conditions and should provide exceptional live cell images.

Chemiluminescent probes are considered to be among the most sensitive diagnostic tools that provide high signal-to-noise ratio for various applications such as DNA detection and immunoassays.

In this regard, investigators at Tel Aviv University have developed a new molecular methodology to design and foresee light-emission properties of turn-ON chemiluminescent dioxetane probes suitable for use under physiological conditions. The methodology is based on incorporation of a substituent on the benzoate species obtained during the chemiexcitation pathway of a Schaap’s adamantylidene–dioxetane probe. A striking substituent effect on the chemiluminescent efficiency of the probes was obtained when acrylate and acrylonitrile electron-withdrawing groups were installed. The chemiluminescent quantum yield of the best probe was more than three orders of magnitude higher than that of a standard, commercially available adamantylidene–dioxetane probe. These may be the most powerful chemiluminescent dioxetane probes synthesized to date that are suitable for use under aqueous conditions.

The investigators reported in the March 8, 2017, online edition of the journal ACS Central Science that one of the probes was capable of providing high-quality chemiluminescent cell images based on the endogenous activity of the enzyme beta-galactosidase. They suggested that this may have been the first demonstration of cell imaging achieved by a non-luciferin small-molecule probe with a direct chemiluminescent mode of emission.

"Chemiluminescence is considered one of the most sensitive methods used in diagnostic testing," said senior author Dr. Doron Shabat, professor of chemistry at Tel Aviv University. "We have developed a method to prepare highly efficient compounds that emit light upon contact with a specific protein or chemical. These compounds can be used as molecular probes to detect cancerous cells, among other applications."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.